Clinical Trial Update: Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ianalumab in adults with primary immune thrombocytopenia and warm autoimmune hemolytic anemia who previously benefited from Ia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia
• Warm Autoimmune Hemolytic Anemia

Drugs mentioned

• Ianalumab (ianalumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Primary Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia | Phase 2 | Status: RECRUITING